C
CytoTools AG
XETRA:T5O
CytoTools AG
XETRA:T5O
Price:
101.26
EUR
0.98%
Market Cap:
€1.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
CytoTools AG
XETRA:T5O
|
DE |
|
OSG Corp
TSE:6136
|
JP |
|
Norfolk Southern Corp
NYSE:NSC
|
US |
|
Tencent Holdings Ltd
HKEX:80700
|
CN |
|
W
|
WeShop Holdings Ltd
NASDAQ:WSHP
|
JE |
|
NMI Holdings Inc
NASDAQ:NMIH
|
US |
|
Natural Health Trends Corp
NASDAQ:NHTC
|
US |
|
Guangdong VTR Bio-Tech Co Ltd
SZSE:300381
|
CN |
|
Sensei Biotherapeutics Inc
F:407
|
US |
|
A
|
Amtd International Inc
NYSE:AMTD
|
HK |
|
Standard Motor Products Inc
NYSE:SMP
|
US |
|
PuraPharm Corp Ltd
HKEX:1498
|
HK |
|
H
|
Heidelbergcement India Ltd
NSE:HEIDELBERG
|
IN |
|
Ufuk Yatirim Yonetim ve Gayrimenkul AS
IST:UFUK.E
|
TR |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is T5O's stock price target?
Not Available
T5O doesn't have any price targets made by Wall Street professionals.
What is CytoTools AG's Revenue forecast?
Projected CAGR
24%
24%
For the last 9 years the compound annual growth rate for CytoTools AG's revenue is -14%. The projected CAGR for the next 1 year is 24%.
